179 related articles for article (PubMed ID: 24301904)
1. Plasma levels of soluble tumor necrosis factor receptors are associated with cognitive performance in Parkinson's disease.
Rocha NP; Teixeira AL; Scalzo PL; Barbosa IG; de Sousa MS; Morato IB; Vieira EL; Christo PP; Palotás A; Reis HJ
Mov Disord; 2014 Apr; 29(4):527-31. PubMed ID: 24301904
[TBL] [Abstract][Full Text] [Related]
2. Brief cognitive assessment in the early stages of Parkinson disease.
Bugalho P; Vale J
Cogn Behav Neurol; 2011 Dec; 24(4):169-73. PubMed ID: 22045168
[TBL] [Abstract][Full Text] [Related]
3. Depression impairs executive functioning in Parkinson disease patients with low educational level.
Kummer A; Harsányi E; Dias FM; Cardoso F; Caramelli P; Teixeira AL
Cogn Behav Neurol; 2009 Sep; 22(3):167-72. PubMed ID: 19741326
[TBL] [Abstract][Full Text] [Related]
4. Neuropsychological correlates of theory of mind in patients with early Parkinson's disease.
Santangelo G; Vitale C; Trojano L; Errico D; Amboni M; Barbarulo AM; Grossi D; Barone P
Mov Disord; 2012 Jan; 27(1):98-105. PubMed ID: 21915910
[TBL] [Abstract][Full Text] [Related]
5. Frontal assessment battery in patients with Parkinson disease in a Turkish population.
Kenangil G; Orken DN; Ur E; Forta H
Cogn Behav Neurol; 2010 Mar; 23(1):26-8. PubMed ID: 20299860
[TBL] [Abstract][Full Text] [Related]
6. The frontal assessment battery as a tool for evaluation of frontal lobe dysfunction in patients with Parkinson disease.
Cohen OS; Vakil E; Tanne D; Molshatzki N; Nitsan Z; Hassin-Baer S
J Geriatr Psychiatry Neurol; 2012 Jun; 25(2):71-7. PubMed ID: 22689698
[TBL] [Abstract][Full Text] [Related]
7. Nondemented Parkinson disease patients: is cognitive performance associated with depressive difficulties?
Klepac N; Trkulja V; Relja M
Cogn Behav Neurol; 2008 Jun; 21(2):87-91. PubMed ID: 18541984
[TBL] [Abstract][Full Text] [Related]
8. Cerebrospinal fluid inflammatory markers in Parkinson's disease--associations with depression, fatigue, and cognitive impairment.
Lindqvist D; Hall S; Surova Y; Nielsen HM; Janelidze S; Brundin L; Hansson O
Brain Behav Immun; 2013 Oct; 33():183-9. PubMed ID: 23911592
[TBL] [Abstract][Full Text] [Related]
9. Levels of TNF-α, soluble TNF receptors (sTNFR1, sTNFR2), and cognition in bipolar disorder.
Doganavsargil-Baysal O; Cinemre B; Aksoy UM; Akbas H; Metin O; Fettahoglu C; Gokmen Z; Davran F
Hum Psychopharmacol; 2013 Mar; 28(2):160-7. PubMed ID: 23532748
[TBL] [Abstract][Full Text] [Related]
10. Deep brain stimulation and cognitive functions in Parkinson's disease: A three-year controlled study.
Zangaglia R; Pacchetti C; Pasotti C; Mancini F; Servello D; Sinforiani E; Cristina S; Sassi M; Nappi G
Mov Disord; 2009 Aug; 24(11):1621-8. PubMed ID: 19514093
[TBL] [Abstract][Full Text] [Related]
11. Depressive symptoms in Parkinson disease correlate with impaired global and specific cognitive performance.
Fernandez HH; See RH; Gary MF; Bowers D; Rodriguez RL; Jacobson C; Okun MS
J Geriatr Psychiatry Neurol; 2009 Dec; 22(4):223-7. PubMed ID: 19429848
[TBL] [Abstract][Full Text] [Related]
12. Is quality of life in non-demented Parkinson's disease patients related to cognitive performance? A clinic-based cross-sectional study.
Klepac N; Trkulja V; Relja M; Babić T
Eur J Neurol; 2008 Feb; 15(2):128-33. PubMed ID: 18217883
[TBL] [Abstract][Full Text] [Related]
13. Cognitive and Motor Aspects of Parkinson's Disease Associated with Dysphagia.
Kim JS; Youn J; Suh MK; Kim TE; Chin J; Park S; Cho JW
Can J Neurol Sci; 2015 Nov; 42(6):395-400. PubMed ID: 26551089
[TBL] [Abstract][Full Text] [Related]
14. The independent influence of apathy and depression on cognitive functioning in Parkinson's disease.
Butterfield LC; Cimino CR; Oelke LE; Hauser RA; Sanchez-Ramos J
Neuropsychology; 2010 Nov; 24(6):721-30. PubMed ID: 20853956
[TBL] [Abstract][Full Text] [Related]
15. Cognitive correlates of visual hallucinations in non-demented Parkinson's disease patients.
Hepp DH; da Hora CC; Koene T; Uitdehaag BM; van den Heuvel OA; Klein M; van de Berg WD; Berendse HW; Foncke EM
Parkinsonism Relat Disord; 2013 Sep; 19(9):795-9. PubMed ID: 23706540
[TBL] [Abstract][Full Text] [Related]
16. Cognitive dysfunctions and pathological gambling in patients with Parkinson's disease.
Santangelo G; Vitale C; Trojano L; Verde F; Grossi D; Barone P
Mov Disord; 2009 Apr; 24(6):899-905. PubMed ID: 19205072
[TBL] [Abstract][Full Text] [Related]
17. Cognitive impairment in incident, untreated Parkinson disease: the Norwegian ParkWest study.
Aarsland D; Brønnick K; Larsen JP; Tysnes OB; Alves G;
Neurology; 2009 Mar; 72(13):1121-6. PubMed ID: 19020293
[TBL] [Abstract][Full Text] [Related]
18. Measuring executive dysfunction in Parkinson's disease: Reliability and validity of the Spanish version of Frontal Assessment Battery (FAB-E).
Hurtado-Pomares M; Terol-Cantero MC; Sánchez-Pérez A; Leiva-Santana C; Peral-Gómez P; Valera-Gran D; Navarrete-Muñoz EM
PLoS One; 2018; 13(11):e0207698. PubMed ID: 30452476
[TBL] [Abstract][Full Text] [Related]
19. Executive dysfunction in non-demented Parkinson's disease patients with hallucinations.
Imamura K; Wada-Isoe K; Kitayama M; Nakashima K
Acta Neurol Scand; 2008 Apr; 117(4):255-9. PubMed ID: 17922890
[TBL] [Abstract][Full Text] [Related]
20. Elevated plasma homocysteine level in patients with Parkinson disease: motor, affective, and cognitive associations.
O'Suilleabhain PE; Sung V; Hernandez C; Lacritz L; Dewey RB; Bottiglieri T; Diaz-Arrastia R
Arch Neurol; 2004 Jun; 61(6):865-8. PubMed ID: 15210523
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
